Related Experiment Video
Updated: Jul 18, 2026

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
Published on: April 30, 2019
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis
John de Kruif1, Alexander B H Bakker, Wilfred E Marissen
1Crucell Holland BV, Leiden, The Netherlands. j.dekruif@crucell.com
Abstract:
The currently recommended treatment for individuals exposed to rabies virus is the combined administration of rabies vaccine and rabies immune globulin (RIG). This review sets out the criteria used to guide development of a cocktail of human monoclonal antibodies as a replacement for RIG. Using this process as a model, the general requirements for development of safe and efficacious monoclonal antibody alternatives to currently used polyclonal serum products are discussed.
Related Concept Videos
Cross-reactivity
Pharmaceutical Poisoning: Treatment Strategies
Rabies
Respiratory Syncytial Virus Disease

